Download PDF
Semin Thromb Hemost 2024; 50(03): 499-516
DOI: 10.1055/s-0043-1777307
Historical Paper

A Critical Reappraisal of the Bleeding Time[*]

R. P. Channing Rodgers
1   Department of Laboratory Medicine, School of Medicine, University of California, San Francisco, California
2   The Veterans Administration Medical Center, San Francisco, California
,
Jack Levin
1   Department of Laboratory Medicine, School of Medicine, University of California, San Francisco, California
2   The Veterans Administration Medical Center, San Francisco, California
› Author Affiliations Funding This work was supported in part by the Veterans Administration; grants from the Research Evaluation and Allocation Committee (School of Medicine) and the Academic Senate of the University of California at San Francisco; a grant from the Research Corporation of Tucson, Arizona; and Research Grant HL 31035 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
› Further Information
    Permissions and Reprints

Abstract

Seminars in Thrombosis and Hemostasis (STH) celebrates 50 years of publishing in 2024. To celebrate this landmark event, STH is republishing some archival material. This manuscript represents the second most highly cited paper ever published in STH. The manuscript published without an abstract, and essentially represented a State of the Art Review on the bleeding time, a relatively invasive procedure that required an incision on the skin or earlobe of a patient, and timing how long it took for the incision to stop bleeding. The bleeding time test was first described in 1901 by the French physician Milian, who presented three studies of bleeding from stab wounds made in the fingertips of healthy and diseased subjects. In 1910, Duke observed the duration of bleeding from small incisions of the ear lobe, and pointed out that the duration of bleeding was increased in instances of reduced platelet counts. The test was subsequently repeatedly modified, and numerous variants of the test, including semiautomated methods, were described by several workers. The most frequently utilised test reflected one described by Ivy and coworkers, who shifted the location of the incision to the volar aspect of the forearm and applied a blood pressure cuff to the arm to maintain a standard venous pressure. The bleeding time has been proposed for use as a diagnostic test for platelet-related bleeding disorders, a measure of efficacy in various forms of therapy, and as a prognosticator of abnormal bleeding. The authors to the current review reevaluated the bleeding time literature using methods to assess the performance of the test in 1990, locating 862 printed documents that discussed the bleeding time, the majority in peer-reviewed professional journals. As this is a republication of archival material, transformed into a modern format, we apologise in advance for any errors introduced during this transformation.

Keywords

skin bleeding time - clinical utility - surgical bleeding risk - platelet count and function - predictor of therapy efficacy

Note

The literature survey on which this study was based was closed at the end of 1986 (although several more recent publications which came to our attention were included). A recent review (Burns ER, Lawrence C: Bleeding time: a guide to its diagnostic and clinical utility. Arch Pathol Laboratory Med 1989;113:1219–1224) contains 26 more recent publications not included in our bibliography. None of the conclusions drawn in the present study are modified by consideration of the data provided by these publications. Although the aforementioned review concludes that there is no evidence to support the use of the bleeding time as a preoperative screening test, it recommends using the test to monitor bleeding in the settings of uremia, von Willebrand's disease, congenital platelet function abnormalities, chronic liver disease, acute alcoholism, aspirin ingestion, anemia, and antibiotic usage. An accompanying editorial (Triplett DA: The bleeding time: neither pariah or panacea. Arch Pathol Laboratory Med 1989;113:1207–1208) further recommends that the test be used in the settings of plastic surgery and major surgery where there is a history of the use of antiplatelet medications. Neither the review nor the editorial makes specific recommendations as to how or when to perform the test or how to interpret its results in any of the recommended clinical settings. Furthermore, none of the cited studies provides such instructions or evidence supporting the recommended uses of the test.


* This article is a republished version of: Rodgers RPC, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990;16(01):1–20.




Publication History

Article published online:
12 December 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Comment to this article:

The Bleeding Time Test in 2024: A Glorious Past and Current ChallengesSemin Thromb Hemost 2024; 50(03): 517-519
DOI: 10.1055/s-0043-1776877

 

  • References

  • 1 Milian MG. Influence de la peau sur la coagulabilite du sang. C R Soc Biol (Paris) 1901; 53: 576-578
    PubMedGoogle Scholar
  • 2 Milian MG. Contribution a l'etude de la coagulation du sang. C R Soc Biol (Paris) 1901; 53: 556-557
    PubMedGoogle Scholar
  • 3 Milian MG. Technique pour l'etude clinique de la coagulation du sang. Bull Mem Soc Med Hop Paris 1901; 18: 777-783
    PubMedGoogle Scholar
  • 4 Duke WW. The relation of blood platelets to hemorrhagic disease. Description of a method for determining the bleeding time and coagulation time and report of three cases of hemorrhagic disease relieved by transfusion. JAMA 1910; 55: 1185-1192
    CrossrefPubMedGoogle Scholar
  • 5 Sutor AH, Bowie EJW, Thompson Jr JH, Didisheim P, Mertens BF, Owen Jr CA. Bleeding from standardized skin punctures: automated technic for recording time, intensity, and pattern of bleeding. Am J Clin Pathol 1971; 55 (05) 541-550
    CrossrefPubMedGoogle Scholar
  • 6 Bowie EJW, Owen Jr CA. Standardization of the bleeding time. Scand J Haematol Suppl 1980; 37: 87-94
    CrossrefPubMedGoogle Scholar
  • 7 Ivy AC, Nelson D, Bucher G. The standardization of certain factors in the cutaneous “venostasis” bleeding time technique. J Lab Clin Med 1941; 26: 1812-1822
    PubMedGoogle Scholar
  • 8 Mielke Jr CH, Kaneshiro MM, Maher IA, Weiner JM, Rapaport SI. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969; 34 (02) 204-215
    CrossrefPubMedGoogle Scholar
  • 9 Babson SR, Babson AL. Development and evaluation of a disposable device for performing simultaneous duplicate bleeding time determinations. Am J Clin Pathol 1978; 70 (03) 406-408
    CrossrefPubMedGoogle Scholar
  • 10 Clinical Laboratories: Opportunities and Threats 1982–1990. Northfield, IL: J. Lloyd Johnson Associates; 1984: 90-92
    PubMedGoogle Scholar
  • 11 Day HJ, Rao AK. Evaluation of platelet function. Semin Hematol 1986; 23 (02) 89-101
    PubMedGoogle Scholar
  • 12 Rodgers RPC, Gardels K, Finkelshtain A. BibIX: A bibliographic data base and text formatting system for UNIX. CALM/MedIX Technical Report 89–1.4. Department of Laboratory Medicine, UCSF School of Medicine, San Francisco; 1989
    PubMedGoogle Scholar
  • 13 Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978; 8 (04) 283-298
    CrossrefPubMedGoogle Scholar
  • 14 Swets JA. ROC analysis applied to the evaluation of medical imaging techniques. Invest Radiol 1979; 14 (02) 109-121
    CrossrefPubMedGoogle Scholar
  • 15 Griner PF, Mayewski RJ, Al Mushlin P. Greenland: selection and interpretation of diagnostic tests and procedures. Ann Intern Med 1981; 4: 553-600
    PubMedGoogle Scholar
  • 16 Metz CE, Wang P, Kronman HB. A new approach for testing the significance of differences between ROC curves measured from correlated data. In: Deconink F. ed. Information Processing in Medical Imaging. VIII. The Hague: Martinus Nijhoff; 1984: 432-445
    Google Scholar
  • 17 Colquhoun D. Lectures on Biostatistics. An Introduction to Statistics with Applications in Biology and Medicine. Clarendon Press, Oxford; 1971
    Google Scholar
  • 18 Knott GD. Mlab – a mathematical modeling tool. Comput Programs Biomed 1979; 10 (03) 271-280
    CrossrefPubMedGoogle Scholar
  • 19 Scott EP, Slichter SJ. Viability and function of platelet concentrates stored in CPD-adenine (CPDA-1). Transfusion 1980; 20 (05) 489-497
    CrossrefPubMedGoogle Scholar
  • 20 Kahn RA, Staggs SD, Miller WV, Heaton WA. Recovery, lifespan, and function of CPD-Adenine (CPDA-1) platelet concentrates stored for up to 72 hours at 4 C. Transfusion 1980; 20 (05) 498-503
    CrossrefPubMedGoogle Scholar
  • 21 Stavem P. The influence of depth of the cut on the bleeding time. Acta Med Scand 1967; 182 (03) 389-396
    CrossrefPubMedGoogle Scholar
  • 22 Borchgrevink CF, Waaler BA. The secondary bleeding time; a new method for the differentiation of hemorrhagic diseases. Acta Med Scand 1958; 162 (05) 361-374
    CrossrefPubMedGoogle Scholar
  • 23 Stavem P. Bleeding time from incisions standardized by protruding skin fold method. Br J Haematol 1974; 26 (01) 153-158
    CrossrefPubMedGoogle Scholar
  • 24 Kahn RA. Clinical evaluation of platelet transfusions in thrombocytopenic patients: methods and interpretation. Vox Sang 1981; 40 (Suppl. 01) 87-97
    CrossrefPubMedGoogle Scholar
  • 25 Göbel U, von Voss H, Jürgens H, Lauber A, Volkmer HP. The reproductiveness of bleeding time tests. Minerva Pediatr 1978; 30 (17) 1391-1396
    PubMedGoogle Scholar
  • 26 Sutor AH, Bowie EJW, Owen Jr CA. Effect of cold on bleeding: Hippocrates vindicated. Lancet 1970; 2 (7682) 1084
    CrossrefPubMedGoogle Scholar
  • 27 Nilsson IM, Magnusson S, Borchgrevink C. The Duke and Ivy methods for determination of the bleeding time. Thromb Diath Haemorrh 1963; 10: 223-234
    PubMedGoogle Scholar
  • 28 Boysen G, Boss AH, Odum N, Olsen JS. Prolongation of bleeding time and inhibition of platelet aggregation by low-dose acetylsalicylic acid in patients with cerebrovascular disease. Stroke 1984; 15 (02) 241-243
    CrossrefPubMedGoogle Scholar
  • 29 Thorngren M, Shafi S, Born GVR. Thromboxane A2 in skin-bleeding-time blood and in clotted venous blood before and after administration of acetylsalicylic acid. Lancet 1983; 1 (8333) 1075-1078
    CrossrefPubMedGoogle Scholar
  • 30 Dyerberg J, Bang HO. Et forslag til tromboseprofylakse. Eskimo-modellen. [Proposed method for the prevention of thrombosis. The Eskimo model] Ugeskr Laeger 1980; 142 (25) 1597-1600
    PubMedGoogle Scholar
  • 31 Thorngren M, Shafi S, Born GVR. Delay in primary haemostasis produced by a fish diet without change in local thromboxane A2. Br J Haematol 1984; 58 (04) 567-578
    CrossrefPubMedGoogle Scholar
  • 32 Knapp HR, Reilly IAG, Alessandrini P, FitzGerald GA. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Engl J Med 1986; 314 (15) 937-942
    CrossrefPubMedGoogle Scholar
  • 33 Jørgensen KA, Dyerberg J, Olesen AS, Stoffersen E. Acetylsalicylic acid, bleeding time and age. Thromb Res 1980; 19 (06) 799-805
    CrossrefPubMedGoogle Scholar
  • 34 Ríos E, Pinochet M, Mandujano TM. Tiempo de sangría de Ivy modificado: valores normales en edad pediátrica. Rev Chil Pediatr 1982; 53 (06) 552-554
    PubMedGoogle Scholar
  • 35 Udén A, Nilsson IM, Willner S. Bleeding time and scoliosis. Acta Orthop Scand 1982; 53 (01) 73-77
    CrossrefPubMedGoogle Scholar
  • 36 Wahlberg TB, Blombäck M, Ruggeri ZM. Differences between heterozygous dominant and recessive von Willebrand's disease type I expressed by bleeding symptoms and combinations of factor VIII variables. Thromb Haemost 1983; 50 (04) 864-868
    Article in Thieme ConnectPubMedGoogle Scholar
  • 37 Sanders JM, Holtkamp CA, Buchanan GR. Bleeding time values in children are longer than in adults. (Abst.). Clin Res 1987; 35: 64A
    PubMedGoogle Scholar
  • 38 O'Brien JR. The bleeding time in normal and abnormal subjects. J Clin Pathol 1951; 4 (03) 272-285
    CrossrefPubMedGoogle Scholar
  • 39 O'Brien JR, Jamieson S, Etherington M, Klaber MR, Ainsworth JF. Stressed template bleeding-time and other platelet-function tests in myocardial infarction. Lancet 1973; 1 (7805) 694-696
    PubMedGoogle Scholar
  • 40 Bain B, Forster T. A sex difference in the bleeding time. Thromb Haemost 1980; 43 (02) 131-132
    Article in Thieme ConnectPubMedGoogle Scholar
  • 41 Punnonen R, Nyman D, Grönroos M, Wallén O. Von Willebrand's disease and pregnancy. Acta Obstet Gynecol Scand 1981; 60 (05) 507-509
    CrossrefPubMedGoogle Scholar
  • 42 O'Brien JR, Etherington MD, Jamieson S, Lawford P, Lincoln SV, Alkjaersig NJ. Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis. Thromb Diath Haemorrh 1975; 34 (02) 483-497
    PubMedGoogle Scholar
  • 43 Caen J, Parquet-Gernez A. Corticotherapie dans les allongements du temps de saignement. [article in French]. Nouv Rev Fr Hematol 1963; 3: 355-361
    PubMedGoogle Scholar
  • 44 Marchal G, Samama M, Dausset J, Prost RJ. La place du temps de saignement dans l'exploration actuelle des thrombopenies. [article in French]. Nouv Rev Fr Hematol 1963; 3: 304-315
    PubMedGoogle Scholar
  • 45 Parquet-Gernez A, Caen J, Goudemand M. Les correlations entre le temps de saignement et l'adhesivite plaquettaire ‘in vivo’ au cours de divers etats hemorrhagiques. Pathol Biol (Paris) 1964; 12: 558-565
    PubMedGoogle Scholar
  • 46 Eknoyan G, Wacksman SJ, Glueck HI, Will JJ. Platelet function in renal failure. N Engl J Med 1969; 280 (13) 677-681
    CrossrefPubMedGoogle Scholar
  • 47 Shulman NR, Watkins Jr SP, Itscoitz SB, Students AB. Evidence that the spleen retains the youngest and hemostatically most effective platelets. Trans Assoc Am Physicians 1968; 81: 302-313
    PubMedGoogle Scholar
  • 48 Harker LA, Slichter SJ. The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 1972; 287 (04) 155-159
    CrossrefPubMedGoogle Scholar
  • 49 Sutor AH, Heidmann M, Künzer W. Die Blutungszeitbestimmung im Kindesalter und ihre klinische Anwendung. Med Welt 1974; 25 (10) 401-404
    PubMedGoogle Scholar
  • 50 McKenna R, Bachmann F, Whittaker B, Gilson JR, Weinberg M. The hemostatic mechanism after open-heart surgery. II. Frequency of abnormal platelet functions during and after extracorporeal circulation. J Thorac Cardiovasc Surg 1975; 70 (02) 298-308
    PubMedGoogle Scholar
  • 51 Hirsh J, Blajchman M, Kaegi A. The bleeding time. In: Day HJ, Holmsen H, Zucker MB. eds. Proceedings, Workshop on Platelets: The Significance of Platelet Function Tests in the Evaluation of Hemostatic and Thrombotic Tendencies. Philadelphia, October 18–19, 1976. DHEW publication no. (NIH) 78–1087, Washington, DC; 1978: 1-11
    PubMedGoogle Scholar
  • 52 Kahn RA, Meryman HT. Storage of platelet concentrates. Transfusion 1976; 16 (01) 13-16
    CrossrefPubMedGoogle Scholar
  • 53 Slichter SJ, Harker LA. Preparation and storage of platelet concentrates. I. Factors influencing the harvest of viable platelets from whole blood. Br J Haematol 1976; 34 (03) 395-402
    CrossrefPubMedGoogle Scholar
  • 54 Murphy S, Davis JL, Walsh PN, Gardner FH. Template bleeding time and clinical hemorrhage in myeloproliferative disease. Arch Intern Med 1978; 138 (08) 1251-1253
    CrossrefPubMedGoogle Scholar
  • 55 Feusner JH. Normal and abnormal bleeding times in neonates and young children utilizing a fully standardized template technic. Am J Clin Pathol 1980; 74 (01) 73-77
    CrossrefPubMedGoogle Scholar
  • 56 Feusner JH, Slichter SJ, Harker LA. Acquired haemostatic defects in the ill newborn. Br J Haematol 1983; 53 (01) 73-84
    CrossrefPubMedGoogle Scholar
  • 57 Rennie JM, Gibson T, Cooke RWI. Micromethod for bleeding time in the newborn. Arch Dis Child 1985; 60 (01) 51-53
    CrossrefPubMedGoogle Scholar
  • 58 Milner PC, Martin JF. Shortened bleeding time in acute myocardial infarction and its relation to platelet mass. Br Med J (Clin Res Ed) 1985; 290 (6484) 1767-1770
    CrossrefPubMedGoogle Scholar
  • 59 Hellem AJ, Borchgrevink CF, Ames SB. The role of red cells in haemostasis: the relation between haematocrit, bleeding time and platelet adhesiveness. Br J Haematol 1961; 7: 42-50
    CrossrefPubMedGoogle Scholar
  • 60 Remuzzi G, Livio M, Marchiaro G, Mecca G, de Gaetano G. Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis. Nephron J 1978; 22 (4-6): 347-353
    CrossrefPubMedGoogle Scholar
  • 61 Stuart MJ, Kelton JG, Allen JB. Abnormal platelet function and arachidonate metabolism in chronic idiopathic thrombocytopenic purpura. Blood 1981; 58 (02) 326-329
    CrossrefPubMedGoogle Scholar
  • 62 Small M, Lowe GDO, Cameron E, Forbes CD. Contribution of the haematocrit to the bleeding time. Haemostasis 1983; 13 (06) 379-384
    PubMedGoogle Scholar
  • 63 Fernandez F, Goudable C, Sie P. et al. Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions. Br J Haematol 1985; 59 (01) 139-148
    CrossrefPubMedGoogle Scholar
  • 64 Hillman CR, Barnhart MI, Lusher JM. Drugs or conditions that alter platelet function. In: Lusher JM, Barnhardt MI. eds. Acquired Bleeding Disorders in Children. Platelet Abnormalities and Laboratory Methods. Masson, New York: 1981: 171-187
    Google Scholar
  • 65 Lind SE. Prolonged bleeding time. Am J Med 1984; 77 (02) 305-312
    CrossrefPubMedGoogle Scholar
  • 66 Deykin D, Janson P, McMahon L. Ethanol potentiation of aspirin-induced prolongation of the bleeding time. N Engl J Med 1982; 306 (14) 852-854
    CrossrefPubMedGoogle Scholar
  • 67 Deykin D, Janson P. The Ponte Vedra syndrome – an unexpected interaction between alcohol and aspirin. Trans Am Clin Climatol Assoc 1982; 93: 121-126
    PubMedGoogle Scholar
  • 68 Dale J, Myhre E, Rootwelt K. Effects of dipyridamole and acetylsalicylic acid on platelet functions in patients with aortic ball-valve prostheses. Am Heart J 1975; 89 (05) 613-618
    CrossrefPubMedGoogle Scholar
  • 69 Kobrinsky NL, Israels ED, Gerrard JM. et al. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders. Lancet 1984; 1 (8387) 1145-1148
    CrossrefPubMedGoogle Scholar
  • 70 Mannucci PM, Vicente V, Vianello L. et al. Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time. Blood 1986; 67 (04) 1148-1153
    CrossrefPubMedGoogle Scholar
  • 71 Maurer HM, Wolff JA, Buckingham S, Spielvogel AR. “Impotent” platelets in albinos with prolonged bleeding times. Blood 1972; 39 (04) 490-499
    CrossrefPubMedGoogle Scholar
  • 72 Bernard J, Soulier J-P. Sur une nouvelle variété de dystrophie thrombocytairehémoŗragipare congénitale. Sem Hop 1948; 24 (Spec. No.): 3217-3223
    PubMedGoogle Scholar
  • 73 Soulier JP. Diagnostic etiologique des allongements du temps de saignement. Nouv Rev Fr Hematol 1963; 3: 299-304
    PubMedGoogle Scholar
  • 74 Tomita Y, Inagaki M, Taki M, Meguro T, Yamada K. [Clinical trial of new bleeding time device (Simplate II) (author's transl)]. Rinsho Ketsueki 1982; 23 (02) 144-149
    PubMedGoogle Scholar
  • 75 Lagarde M, Byron PA, Vargaftig BB, Dechavanne M. Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase. Br J Haematol 1978; 38 (02) 251-266
    CrossrefPubMedGoogle Scholar
  • 76 Pareti FI, Mannucci PM, D'Angelo A, Smith JB, Sautebin L, Galli G. Congenital deficiency of thromboxane and prostacyclin. Lancet 1980; 1 (8174) 898-901
    CrossrefPubMedGoogle Scholar
  • 77 Rak K, Boda Z. Haemostatic balance in congenital deficiency of platelet cyclo-oxygenase. (Letter) Lancet 1980; 2 (8184) 44
    CrossrefPubMedGoogle Scholar
  • 78 Horellou MH, Lecompte T, Lecrubier C. et al. Familial and constitutional bleeding disorder due to platelet cyclo-oxygenase deficiency. Am J Hematol 1983; 14 (01) 1-9
    CrossrefPubMedGoogle Scholar
  • 79 Zahavi J, Marder VJ. Acquired “storage pool disease” of platelets associated with circulating antiplatelet antibodies. Am J Med 1974; 56 (06) 883-890
    CrossrefPubMedGoogle Scholar
  • 80 Weiss HJ, Rosove MH, Lages BA, Kaplan KL. Acquired storage pool deficiency with increased platelet-associated IgG. Report of five cases. Am J Med 1980; 69 (05) 711-717
    CrossrefPubMedGoogle Scholar
  • 81 Weening RS, Schoorel EP, Roos D. et al. Effect of ascorbate on abnormal neutrophil, platelet and lymphocytic function in a patient with the Chediak-Higashi syndrome. Blood 1981; 57 (05) 856-865
    CrossrefPubMedGoogle Scholar
  • 82 Borchgrevink CF. Platelet adhesion in vivo in patients with bleeding disorders. Acta Med Scand 1961; 170: 231-243
    CrossrefPubMedGoogle Scholar
  • 83 Larrieu M-J, Caen J, Lelong J-C, Bernard J. Maladie de Glanzmann. Etude clinique, biologique et pathogenique a propos de cinq observations. Nouv Rev Fr Hematol 1961; 1: 662-693
    PubMedGoogle Scholar
  • 84 Caen JP, Castaldi PA, Leclerc JC. et al. Congenital bleeding disorders with long bleeding time and normal platelet count. I. Glanzmann's thrombasthenia (report of fifteen patients). Am J Med 1966; 41: 4-26
    CrossrefPubMedGoogle Scholar
  • 85 Brown III CH, Weisberg RJ, Natelson EA, Alfrey Jr CP. Glanzmann's thrombasthenia; assessment of the response to platelet transfusions. Transfusion 1975; 15 (02) 124-131
    CrossrefPubMedGoogle Scholar
  • 86 Perkin RF, White GC, Webster WP. Glanzmann's thrombasthenia. Report of two oral surgical cases using a new microfibrillar collagen preparation and EACA for hemostasis. Oral Surg Oral Med Oral Pathol 1979; 47 (01) 36-39
    PubMedGoogle Scholar
  • 87 Sundqvist S-B, Nilsson IM, Svanberg L, Cronberg S. Pregnancy and parturition in a patient with severe Glanzmann's thrombasthenia. Scand J Haematol 1981; 27 (03) 159-164
    CrossrefPubMedGoogle Scholar
  • 88 Pareti FI, Capitanio A, Mannucci L, Ponticelli C, Mannucci PM. Acquired dysfunction due to the circulation of “exhausted” platelets. Am J Med 1980; 69 (02) 235-240
    CrossrefPubMedGoogle Scholar
  • 89 Mori K, Suzuki S, Sugai K. Electron microscopic and functional studies on platelets in gray platelet syndrome. Tohoku J Exp Med 1984; 143 (03) 261-287
    CrossrefPubMedGoogle Scholar
  • 90 Gerritsen SW, Akkerman J-WN, Sixma JJ. Correction of the bleeding time in patients with storage pool deficiency by infusion of cryoprecipitate. Br J Haematol 1978; 40 (01) 153-160
    CrossrefPubMedGoogle Scholar
  • 91 DePinho RA, Kaplan KL. The Hermansky-Pudlak syndrome. Report of three cases and review of pathophysiology and management considerations. Medicine (Baltimore) 1985; 64 (03) 192-202
    CrossrefPubMedGoogle Scholar
  • 92 Hutter JJ, Hathaway WE. Prednisone-induced hemostasis in a platelet function abnormality. Am J Dis Child 1975; 129 (05) 641-643
    PubMedGoogle Scholar
  • 93 Pareti FI, Gugliotta L, Mannucci L, Guarini A, Mannucci PM. Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders. Thromb Haemost 1982; 47 (02) 84-89
    Article in Thieme ConnectPubMedGoogle Scholar
  • 94 Barbui T, Cortelazzo S, Viero P, Bassan R, Dini E, Semeraro N. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function. Eur J Cancer Clin Oncol 1983; 19 (11) 1593-1599
    CrossrefPubMedGoogle Scholar
  • 95 Lintula R, Rasi V, Ikkala E, Borgström GH, Vuopio P. Platelet function in preleukaemia. Scand J Haematol 1981; 26 (01) 65-71
    CrossrefPubMedGoogle Scholar
  • 96 Malpass TW, Savage B, Hanson SR, Slichter SJ, Harker LA. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders. J Lab Clin Med 1984; 103 (06) 894-904
    PubMedGoogle Scholar
  • 97 Uchiyama S, Bach ML, Didisheim P, Bowie EJW. Clinical evaluation of a new test of hemostasis: the Filter Bleeding Time. Thromb Res 1984; 34 (05) 397-405
    CrossrefPubMedGoogle Scholar
  • 98 Sutor AH, Bowie EJW, Owen Jr CA. Effect of temperature on hemostasis: a cold-tolerance test. Blut 1971; 22 (01) 27-34
    CrossrefPubMedGoogle Scholar
  • 99 Quick AJ. The vascular component in hemostasis. N Engl J Med 1970; 283 (04) 186-189
    CrossrefPubMedGoogle Scholar
  • 100 Lewis JH, Burchenal JH, Ellison RR. et al. Studies of hemostatic mechanisms in leukemia and thrombocytopenia. Am J Clin Pathol 1957; 28 (05) 433-446
    CrossrefPubMedGoogle Scholar
  • 101 Perry S. Coagulation defects in leukemia. J Lab Clin Med 1957; 50 (02) 229-241
    PubMedGoogle Scholar
  • 102 Friedman IA, Schwartz SO, Leithold SL. Platelet function defects with bleeding. Arch Intern Med 1964; 113: 177-185
    CrossrefPubMedGoogle Scholar
  • 103 McClure PD, Ingram GIC, Stacey RS, Glass UH, Matchett MO. Platelet function tests in thrombocythaemia and thrombocytosis. Br J Haematol 1966; 12 (04) 478-498
    CrossrefPubMedGoogle Scholar
  • 104 Zucker S, Mielke CH. Classification of thrombocytosis based on platelet function tests: correlation with hemorrhagic and thrombotic complications. J Lab Clin Med 1972; 80 (03) 385-394
    PubMedGoogle Scholar
  • 105 Herrmann FH, Meyer M, Lagutina NJ, Tchishova AI, Gavrilov OK. Additional glycoprotein abnormalities in a rare type of thrombasthenia. Thromb Res 1982; 28 (06) 825-830
    CrossrefPubMedGoogle Scholar
  • 106 Brox JH, Killie JE, Osterud B, Holme S, Nordøy A. Effects of cod liver oil on platelets and coagulation in familial hypercholesterolemia (type IIa). Acta Med Scand 1983; 213 (02) 137-144
    CrossrefPubMedGoogle Scholar
  • 107 Joist JH, Baker RK, Schonfeld G. Increased in vivo and in vitro platelet function in type II- and type IV-hyperlipoproteinemia. Thromb Res 1979; 15 (1-2) 95-108
    CrossrefPubMedGoogle Scholar
  • 108 Blatrix C. Allongement du temps de saignement sous 1'influence de certains medicaments. Nouv Rev Fr Hematol 1963; 3: 346-350
    PubMedGoogle Scholar
  • 109 Gast LF. Influence of aspirin on haemostatic parameters. Ann Rheum Dis 1964; 23 (06) 500-504
    CrossrefPubMedGoogle Scholar
  • 110 Sahud MA, Cohen RJ. Aspirin-induced prolongation of the ivy bleeding time. Its diagnostic usefulness. Calif Med 1971; 115 (04) 10-13
    PubMedGoogle Scholar
  • 111 ten Cate JW, de Vries SI, Sixma JJ, van Berkel W. Reproducibility and normal values of various platelet function tests. Folia Med Neerl 1972; 15 (01) 10-20
    PubMedGoogle Scholar
  • 112 Mielke CH, Heiden D, Amadio P. Tolmetin: hematological effects in normal subjects. In: Ward JR. ed. Tolmetin: A New Non-Steroidal Anti-Inflammatory Agent. Excerpta Medica, Amsterdam; 1976: 200-208
    Google Scholar
  • 113 Kumar R, Ansell JE, Canoso RT, Deykin D. Clinical trial of a new bleeding-time device. Am J Clin Pathol 1978; 70 (04) 642-645
    CrossrefPubMedGoogle Scholar
  • 114 Thong KL, Mant MJ, Grace MG. Lack of effect of prednisone administration on bleeding time and platelet function of normal subjects. Br J Haematol 1978; 38 (03) 373-380
    CrossrefPubMedGoogle Scholar
  • 115 Schwartz BS, Leis LA, Johnson GJ. In vivo platelet retention in human bleeding-time wounds. II. Effect of aspirin ingestion. J Lab Clin Med 1979; 94 (04) 574-584
    PubMedGoogle Scholar
  • 116 Stuart MJ, Miller ML, Davey FR, Wolk JA. The post-aspirin bleeding time: a screening test for evaluating haemostatic disorders. Br J Haematol 1979; 43 (04) 649-659
    CrossrefPubMedGoogle Scholar
  • 117 Jiménez R, Barrantes A, Mora LA, Flores V, Solano T. Evaluación del tiempo de sangrado por dos métodos diferentes. Sangre (Barc) 1981; 26 (5-A): 588-594
    PubMedGoogle Scholar
  • 118 Mielke Jr CH. Comparative effects of aspirin and acetaminophen on hemostasis. Arch Intern Med 1981; 141 (3 Spec No): 305-310
    CrossrefPubMedGoogle Scholar
  • 119 Harada K, Kawai Y. Evaluation of bleeding time using Simplate–comparison with the Duke method. [article in Japanese]. Rinsho Byori 1982; 30 (12) 1379-1383
    PubMedGoogle Scholar
  • 120 Bain B, Forster T, Baker A. An assessment of the sensitivity of 3 bleeding time techniques. Scand J Haematol 1983; 30 (04) 311-316
    CrossrefPubMedGoogle Scholar
  • 121 Ferraris VA, Swanson E. Aspirin usage and perioperative blood loss in patients undergoing unexpected operations. Surg Gynecol Obstet 1983; 156 (04) 439-442
    PubMedGoogle Scholar
  • 122 Willoughby MLN, Crouch SJ. An investigation of the haemorrhagic tendency in renal failure. Br J Haematol 1961; 7: 315-326
    CrossrefPubMedGoogle Scholar
  • 123 Hutton RA, O'Shea MJ. Haemostatic mechanism in uraemia. J Clin Pathol 1968; 21 (03) 406-411
    CrossrefPubMedGoogle Scholar
  • 124 Steiner RW, Coggins C, Carvalho ACA. Bleeding time in uremia: a useful test to assess clinical bleeding. Am J Hematol 1979; 7 (02) 107-117
    CrossrefPubMedGoogle Scholar
  • 125 Simon TL, Akl BF, Murphy W. Controlled trial of routine administration of platelet concentrates in cardiopulmonary bypass surgery. Ann Thorac Surg 1984; 37 (05) 359-364
    CrossrefPubMedGoogle Scholar
  • 126 Barber A, Green D, Galluzzo T, Ts'ao C-H. The bleeding time as a preoperative screening test. Am J Med 1985; 78 (05) 761-764
    CrossrefPubMedGoogle Scholar
  • 127 Ewe K. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 1981; 26 (05) 388-393
    CrossrefPubMedGoogle Scholar
  • 128 Weiss HJ, Aledort LM, Kochwa S. The effect of salicylates on the hemostatic properties of platelets in man. J Clin Invest 1968; 47 (09) 2169-2180
    CrossrefPubMedGoogle Scholar
  • 129 Nadell J, Bruno J, Varady J, Segre EJ. Effect of naproxen and of aspirin on bleeding time and platelet aggregation. J Clin Pharmacol 1974; 14 (04) 176-182
    CrossrefPubMedGoogle Scholar
  • 130 David J-L, Monfort F, Herion F, Raskinet R. Compared effects of three dose-levels of ticlopidine on platelet function in normal subjects. Thromb Res 1979; 14 (01) 35-49
    CrossrefPubMedGoogle Scholar
  • 131 Pauwen LJ, Roskam J, Derouaux G, Puissant A. Etude statistique du temps de saignement moyen humain. Mise au point d'une methode pour 1‘exploration, chez l’homme, de l'hemostase spontanee et de ses variations sous 1'influence des medicaments ainsi que de divers facteurs physio-pathologiques. Arch Int Pharmacodyn 1942; 67: 390-424
    PubMedGoogle Scholar
  • 132 Copley AL. Editorial: Bleeding time, other in vivo hemostasis tests and the arrest of hemorrhage. Thromb Res 1974; 4 (01) 1-23
    CrossrefPubMedGoogle Scholar
  • 133 Göbel U, Volkmer H-P, Petrich C, von Voss H. Vergleichende Untersuchungen zur Bestimmung der Blutungszeit. Dtsch Med Wochenschr 1976; 101 (03) 81-83
    Article in Thieme ConnectPubMedGoogle Scholar
  • 134 Abildgaard CF, Suzuki Z, Harrison J, Jefcoat K, Zimmerman TS. Serial studies in von Willebrand's disease: variability versus “variants”. Blood 1980; 56 (04) 712-716
    CrossrefPubMedGoogle Scholar
  • 135 Uchiyama S, Stropp JQ, Claypool DA, Didisheim P. Filter bleeding time: a new in vitro test of hemostasis. II. Application to the study of von Willebrand disease and platelet function inhibitors. Thromb Res 1983; 31 (01) 117-125
    CrossrefPubMedGoogle Scholar
  • 136 Uchiyama S, Stropp JQ, Claypool DA, Didisheim P, Dewanjee MK. Filter bleeding time: a new in vitro test of hemostasis. I. Evaluation in normal and thrombocytopenic subjects. Thromb Res 1983; 31 (01) 99-115
    CrossrefPubMedGoogle Scholar
  • 137 Poller L, Thomson JM, Tomenson JA. The bleeding time: current practice in the UK. Clin Lab Haematol 1984; 6 (04) 369-373
    CrossrefPubMedGoogle Scholar
  • 138 McGill M. Correlations of platelet survival and function with the results of two in vitro tests. Vox Sang 1981; 40 (Suppl. 01) 98-109
    CrossrefPubMedGoogle Scholar
  • 139 Liebman H, Chinowsky M, Valdin J, Kenoyer G, Feinstein D. Increased fibrinolysis and amyloidosis. Arch Intern Med 1983; 143 (04) 678-682
    CrossrefPubMedGoogle Scholar
  • 140 O'Reagan SO, Rivard GE, Mongeau J-G, Robitaille PO. A circulating inhibitor of platelet aggregation in Bartter's syndrome. Pediatrics 1979; 64 (06) 939-941
    CrossrefPubMedGoogle Scholar
  • 141 Kao K-J, Coleman RA, Pizzo SV. The bleeding diathesis in human glycogen storage disease type I: in vitro identification of a naturally occurring inhibitor of ristocetin-induced platelet aggregation. Thromb Res 1980; 18 (05) 683-692
    CrossrefPubMedGoogle Scholar
  • 142 Alagille D, Goffaux J. Le temps de saignement au cours des cardiopathies congenitales. [article in French]. Nouv Rev Fr Hematol 1963; 3: 327-334
    PubMedGoogle Scholar
  • 143 Ekert H, Gilchrist GS, Stanton R, Hammond D. Hemostasis in cyanotic congenital heart disease. J Pediatr 1970; 76 (02) 221-230
    CrossrefPubMedGoogle Scholar
  • 144 Udén A, Nilsson IM. Correlation between the bleeding time and the platelet aggregating activity of collagen in scoliosis. Thromb Res 1979; 16 (1-2): 93-95
    CrossrefPubMedGoogle Scholar
  • 145 Udén A, Nilsson IM, Willner S. Collagen-induced platelet aggregation and bleeding time in adolescent idiopathic scoliosis. Acta Orthop Scand 1980; 51 (05) 773-777
    CrossrefPubMedGoogle Scholar
  • 146 Caen J, Legrand Y, Sultan Y, Cronberg S, Jeanneau C, Pignaud G. Allongement du temps de saignement et anomalies du collagène. Nouv Rev Fr Hematol 1970; 10 (03) 426-430
    PubMedGoogle Scholar
  • 147 Hathaway WE, Solomons CC, Ott JE. Platelet function and pyrophosphates in osteogenesis imperfecta. Blood 1972; 39 (04) 500-509
    CrossrefPubMedGoogle Scholar
  • 148 Evensen SA, Myhre L, Stormorken H. Haemostatic studies in osteogenesis imperfecta. Scand J Haematol 1984; 33 (02) 177-179
    CrossrefPubMedGoogle Scholar
  • 149 Udén A. Collagen and bleeding diathesis in Ehlers-Danlos syndrome. Scand J Haematol 1982; 28 (05) 425-430
    CrossrefPubMedGoogle Scholar
  • 150 Lacombe M, Soria J, Soria C, D'Angelo G, Lavallee R, Bonny Y. Fibrinogen Montreal. A new case of congenital dysfibrinogenemia with defective aggregation of monomers. Thromb Diath Haemorrh 1973; 29 (03) 536-546
    PubMedGoogle Scholar
  • 151 Yamagata S, Mori K, Kayaba T, Hiratsuka I, Kitamura T. A case of congenital afibrinogenemia and review of reported cases in Japan. Tohoku J Exp Med 1968; 96 (01) 15-35
    CrossrefPubMedGoogle Scholar
  • 152 Caen J, Inceman S. Considerations sur l'allongement du temps de saignement dans l'afibrogenemie congenitale. Nouv Rev Fr Hematol 1963; 3: 614-615
    PubMedGoogle Scholar
  • 153 Weiss HJ, Rogers J. Fibrinogen and platelets in the primary arrest of bleeding. Studies in two patients with congenital afibrinogenemia. N Engl J Med 1971; 285 (07) 369-374
    CrossrefPubMedGoogle Scholar
  • 154 O'Brien JR. Factor V in blood coagulation in vitro, and a report of a case of factor-V deficiency. Br J Haematol 1958; 4 (02) 210-219
    CrossrefPubMedGoogle Scholar
  • 155 Rush B, Ellis H. The treatment of patients with factor-V deficiency. Thromb Diath Haemorrh 1965; 14 (1-2): 74-82
    PubMedGoogle Scholar
  • 156 Breederveld K, van Royen EA, Ten Cate JW. Severe factor V deficiency with prolonged bleeding time. Thromb Diath Haemorrh 1974; 32 (2-3): 538-548
    PubMedGoogle Scholar
  • 157 Sheridan BL, Fraser E, Tay W, Hayne OA. The Simplate bleeding time: a retrospective analysis. (Abst. 978.). Blood 1983; 62 (Suppl l ): 268a
    PubMedGoogle Scholar
  • 158 Mazzucconi MG, Mandelli F, Mariani G, Briët E, Veltkamp JJ. A CRM-Positive variant of factor-VII deficiency and the detection of heterozygotes with the assay of factor-like antigen. Br J Haematol 1977; 36 (01) 127-135
    CrossrefPubMedGoogle Scholar
  • 159 Ly B, Solum NO, Vennerød AM, Dahl O, Hagen I, Orstavik KH. A syndrome of factor VII deficiency and abnormal platelet release reaction. Scand J Haematol 1978; 21 (03) 206-214
    CrossrefPubMedGoogle Scholar
  • 160 Zimmermann R, Ehlers G, Ehlers W, von Voss H, Göbel U, Wahn U. Congenital factor VII deficiency. A report of four new cases. Blut 1979; 38 (02) 119-125
    CrossrefPubMedGoogle Scholar
  • 161 Bhavnani M, Evans DIK. Carriers of factor VII deficiency are not always asymptomatic. Clin Lab Haematol 1984; 6 (04) 363-368
    CrossrefPubMedGoogle Scholar
  • 162 Larrieu M-J, Soulier JP. Deficit en facteur antihemophilique A chez une fille, associe a un trouble du saignement. Rev Haematol 1953; 8: 361-370
    PubMedGoogle Scholar
  • 163 Nilsson IM, Blomback M, Von Francken I. On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta Med Scand 1957; 159 (01) 35-57
    CrossrefPubMedGoogle Scholar
  • 164 Borchgrevink CF, Owren PA. The hemostatic effect of normal platelets in hemophilia and factor V deficiency. The importance of clotting factors adsorbed on platelets for normal hemostasis. Acta Med Scand 1961; 170: 375-383
    CrossrefPubMedGoogle Scholar
  • 165 Kaneshiro MM, Mielke Jr CH, Kasper CK, Rapaport SI. Bleeding time after aspirin in disorders of intrinsic clotting. N Engl J Med 1969; 281 (19) 1039-1042
    CrossrefPubMedGoogle Scholar
  • 166 Brody JI. Prolonged bleeding times with factor IX and XI deficiency von Willebrand's syndromes. Am J Med Sci 1975; 269 (01) 19-24
    CrossrefPubMedGoogle Scholar
  • 167 Buchanan GR, Holtkamp CA. Prolonged bleeding time in children and young adults with hemophilia. Pediatrics 1980; 66 (06) 951-955
    CrossrefPubMedGoogle Scholar
  • 168 Hasiba U, Scranton PE, Lewis JH, Spero JA. Efficacy and safety of ibuprofen for hemophilic arthropathy. Arch Intern Med 1980; 140 (12) 1583-1585
    CrossrefPubMedGoogle Scholar
  • 169 Eyster ME, Gordon RA, Ballard JO. The bleeding time is longer than normal in hemophilia. Blood 1981; 58 (04) 719-723
    CrossrefPubMedGoogle Scholar
  • 170 Bussel J, Inman R, Schulman I, Miller C, Hilgartner M. Abnormal platelet function in hemophilia: role of immune complexes and platelet antibodies. (Abst. 872.). Blood 1983; 62 (Suppl l ): 242a
    PubMedGoogle Scholar
  • 171 Smith PS, Baglini R, Meissner GF. The prolonged bleeding time in hemophilia A: comparison of two measuring technics and clinical associations. Am J Clin Pathol 1985; 83 (02) 211-215
    CrossrefPubMedGoogle Scholar
  • 172 Sjolin KE, Videbaek A. Christmas factor deficiency and decreased capillary resistance in a female with haemorrhagic diathesis. Dan Med Bull 1956; 3 (03) 85-87
    PubMedGoogle Scholar
  • 173 Combrisson-Le Bolloch A, Debray J, Benhamou JP. Deficit en facteur antihemophilique B associe a un allongement du temps de saignement. Sang (Paris) 1957; 28: 137-138
    PubMedGoogle Scholar
  • 174 Soulier JP, Larrieu MJ. Deficit en facteur antihemophilique B avec allongement du temps de saignement. Sang (Paris) 1957; 28: 138-141
    PubMedGoogle Scholar
  • 175 Frick PG, Bachmann F, Duckert F. Vascular anomaly associated with plasma thromboplastin antecedent deficiency. J Lab Clin Med 1959; 54: 680-684
    PubMedGoogle Scholar
  • 176 Blackburn EK, Monaghan JH, Lederer H, Macfie JM. Christmas disease associated with primary capillary abnormalities. BMJ 1962; 1 (5272) 154-156
    CrossrefPubMedGoogle Scholar
  • 177 Dormandy K, Hardisty RM, Macpherson J. Christmas disease and capillary abnormality. BMJ 1962; 1: 566-567
    CrossrefPubMedGoogle Scholar
  • 178 Brown III CH, Kvols LK, Hsu T-H, Levin J. Factor IX deficiency and bleeding in a patient with Sheehan's syndrome. Blood 1972; 39 (05) 650-657
    CrossrefPubMedGoogle Scholar
  • 179 Bounameaux Y. Coagulopathies avec temps de saignement prolongé. Thromb Diath Haemorrh 1963; 9: 417-426
    PubMedGoogle Scholar
  • 180 Owren PA. Physiopathology of bleeding time. [article in French]. Nouv Rev Fr Hematol 1963; 3: 280-290
    PubMedGoogle Scholar
  • 181 Edgin RA, Metz EN, Fromkes JJ, Beman FM. Acquired factor X deficiency with associated defects in platelet aggregation. A response to corticosteroid therapy. Am J Med 1980; 69 (01) 137-139
    CrossrefPubMedGoogle Scholar
  • 182 Ramot B, Fisher S. Plasma thromboplastin antecedent deficiency and its association with pseudohemophilia. A report of 2 cases. Isr Med J 1960; 19: 85-88
    PubMedGoogle Scholar
  • 183 White JG, Yunis E, Colliander M, Krivit W. Prolonged bleeding time in a patient with plasma thromboplastin antecedent deficiency: Observations on correction of the bleeding time by platelet transfusion. J Pediatr 1963; 63: 1081-1086
    CrossrefPubMedGoogle Scholar
  • 184 Karaca M, Nilsson IM. PTA (factor XI) deficiency and prolonged bleeding time. Acta Med Scand 1972; 192 (03) 171-176
    CrossrefPubMedGoogle Scholar
  • 185 Winter M, Needham J, Barkhan P. Factor XI deficiency and a platelet defect. Haemostasis 1983; 13 (02) 83-88
    PubMedGoogle Scholar
  • 186 Sutor AH, Bowie EJW, Owen CA. Clinical application of a new quantitative bleeding time test. (Abst. 91.). Blood 1970; 36: 855
    PubMedGoogle Scholar
  • 187 Aballi AJ, De Lamerens S. Coagulation changes in the neonatal period and in early infancy. Pediatr Clin North Am 1962; 9: 785-817
    CrossrefPubMedGoogle Scholar
  • 188 Caen JP, Sultan Y, Delobel J. Les thrombopathies acquises. Nouv Rev Fr Hematol 1969; 9 (04) 553-569
    PubMedGoogle Scholar
  • 189 Praga C, Valentini L, Maiorano M, Cortellaro M. A new automatic device for the standardized Ivy bleeding time. In: Mannucci PM, Gorini S. eds. Platelet Function and Thrombosis. A Review of Methods. Plenum Press; New York: 1972: 271-280
    Google Scholar
  • 190 Stuart MJ. Platelet dysfunction in homozygous β-thalassemia. Pediatr Res 1979; 13 (12) 1345-1349
    CrossrefPubMedGoogle Scholar
  • 191 McNealy RW, Shapiro PF, Melnick P. The effect of viosterol in jaundice. Surg Gynecol Obstet 1935; 60: 785-801
    PubMedGoogle Scholar
  • 192 de Nicola P, Candura MD. Etude de l'intensité du saignement dans la determination du temps de saignement. Hemostase 1961; 1: 113-124
    PubMedGoogle Scholar
  • 193 Mènache D. L'atteinte du temps de saignement en pathologie hépatique. Nouv Rev Fr Hematol 1963; 3: 337-340
    PubMedGoogle Scholar
  • 194 Audhuy B, Doffoel M, Wiesel ML, Hemmendinger S, Cazenave JP, Bockel R. Importance des troubles de l'hémostase primaire dans la survenue des hémorragies digestives hautes du cirrhotique. Ann Gastroenterol Hepatol (Paris) 1984; 20 (04) 177-182
    PubMedGoogle Scholar
  • 195 Linné T. Prolonged bleeding time in non-uremic acute glomerulonephritis. Thromb Haemost 1979; 42 (03) 1060-1061
    Article in Thieme ConnectPubMedGoogle Scholar
  • 196 Edson JR, Fecher DR, Doe RP. Low platelet adhesiveness and other hemostatic abnormalities in hypothyroidism. Ann Intern Med 1975; 82 (03) 342-346
    CrossrefPubMedGoogle Scholar
  • 197 Fuse Y, Shirai T. [Hematological changes related to coagulation in toxemia of pregnancy –in reference to postpartum hemorrhage (author's transl)]. Acta Obstet Gynaecol Jpn 1981; 33 (04) 506-512
    PubMedGoogle Scholar
  • 198 Fuse Y. [Hematocoagulatological changes in toxemia of pregnancy–in reference to clinical symptom (author's transl)]. Nippon Sanka Fujinka Gakkai Zasshi 1982; 34 (05) 618-626
    PubMedGoogle Scholar
  • 199 Weenink GH, Treffers PE, ten Cate JW, Smorenberg-Schoorl ME. Stollinsstoornissen bij zwangerschapstoxicose en preëclampsie. Ned Tijdschr Geneeskd 1984; 128: 1985-1989
    PubMedGoogle Scholar
  • 200 Heiden D, Mielke Jr CH, Rodvien R. Impairment by heparin of primary haemostasis and platelet [14C]5-hydroxytryptamine release. Br J Haematol 1977; 36 (03) 427-436
    CrossrefPubMedGoogle Scholar
  • 201 Heiden D, Rodvien R, Mielke Jr CH. Heparin bleeding due to qualitative platelet dysfunction. Angiology 1979; 30 (09) 645-648
    CrossrefPubMedGoogle Scholar
  • 202 Heiden D, Rodvien R, Mielke CH. Heparin bleeding, platelet dysfunction, and aspirin. (Letter.) JAMA 1981; 246 (04) 330-331
    CrossrefPubMedGoogle Scholar
  • 203 Ludlam CA. Assessment of platelet function. In: Bloom AL, Thomas DP. eds. Haemostasis and Thrombosis. Churchill Livingstone, Edinburgh; 1981: 775-795
    Google Scholar
  • 204 Livio M, Gotti E, Marchesi D, Mecca G, Remuzzi G, de Gaetano G. Uraemic bleeding: role of anaemia and beneficial effect of red cell transfusions. Lancet 1982; 2 (8306) 1013-1015
    CrossrefPubMedGoogle Scholar
  • 205 Gotti E, Mecca G, Valentino C, Cortinovis E, Bertani T, Remuzzi G. Renal biopsy in patients with acute renal failure and prolonged bleeding time. Lancet 1984; 2 (8409) 978-979
    CrossrefPubMedGoogle Scholar
  • 206 Moia M, Mannucci PM, Vizzotto L, Casati S, Cattaneo M, Ponticelli C. Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin. Lancet 1987; 2 (8570) 1227-1229
    CrossrefPubMedGoogle Scholar
  • 207 Saniabadi AR, Lowe GDO, Barbenel JC, Forbes CD. Haematocrit, bleeding time, and platelet aggregation. (Letter.) Lancet 1984; 1 (8391) 1409-1411
    CrossrefPubMedGoogle Scholar
  • 208 O'Laughlin JC, Hoftiezer JW, Mahoney JP, Ivey KJ. Does aspirin prolong bleeding from gastric biopsies in man?. Gastrointest Endosc 1981; 27 (01) 1-5
    CrossrefPubMedGoogle Scholar
  • 209 Diamond LK, Porter FS. The inadequacies of routine bleeding and clotting times. N Engl J Med 1958; 259 (21) 1025-1027
    CrossrefPubMedGoogle Scholar
  • 210 Dieter Jr RA, Neville WE, Pifarre R, Jasuja M. Preoperative coagulation profiles and posthemodilution cardiopulmonary bypass hemorrhage. Am J Surg 1971; 121 (06) 689-693
    CrossrefPubMedGoogle Scholar
  • 211 Dale J, Myhre E. Platelet functions in patients with aortic ball valves. Am Heart J 1977; 94 (03) 359-366
    CrossrefPubMedGoogle Scholar
  • 212 Installe E, Gonzalez M, Schoevaerdts JC, Tremouroux J. Prevention by ticlopidine of platelet consumption during extracorporeal circulation for heart surgery and lack of effect on operative and postoperative bleeding. J Cardiovasc Pharmacol 1981; 3 (06) 1174-1183
    CrossrefPubMedGoogle Scholar
  • 213 Ramsey G, Arvan DA, Stewart S, Blumberg N. Do preoperative laboratory tests predict blood transfusion needs in cardiac operations?. J Thorac Cardiovasc Surg 1983; 85 (04) 564-569
    CrossrefPubMedGoogle Scholar
  • 214 Burns ER, Billett HH, Frater RWM, Sisto DA. The preoperative bleeding time as a predictor of postoperative hemorrhage after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1986; 92 (02) 310-312
    CrossrefPubMedGoogle Scholar
  • 215 Salzman EW, Weinstein MJ, Weintraub RM. et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. N Engl J Med 1986; 314 (22) 1402-1406
    CrossrefPubMedGoogle Scholar
  • 216 Bachmann F, McKenna R, Cole ER, Najafi H. The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. J Thorac Cardiovasc Surg 1975; 70 (01) 76-85
    PubMedGoogle Scholar
  • 217 Harker LA, Malpass TW, Branson HE, Hessel II EA, Slichter SJ. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective α-granule release. Blood 1980; 56 (05) 824-834
    PubMedGoogle Scholar
  • 218 Amrein PC, Ellman L, Harris WH. Aspirin-induced prolongation of bleeding time and perioperative blood loss. JAMA 1981; 245 (18) 1825-1828
    CrossrefPubMedGoogle Scholar
  • 219 Eika C, Havig O, Godal HC. The value of preoperative haemostatic screening. Scand J Haematol 1978; 21 (04) 349-354
    CrossrefPubMedGoogle Scholar
  • 220 Glick R, Green D, Ts'ao C, Witt WA, Yu ATW, Raimondi AJ. High does epsilon-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage. Neurosurgery 1981; 9 (04) 398-401
    CrossrefPubMedGoogle Scholar
  • 221 Harris S, Nilsson IM. Preoperative test of bleeding time in ear surgery. Acta Otolaryngol 1980; 89 (5-6): 474-478
    CrossrefPubMedGoogle Scholar
  • 222 Diaz-Buxo JA, Donadio Jr JV. Complications of percutaneous renal biopsy: an analysis of 1,000 consecutive biopsies. Clin Nephrol 1975; 4 (06) 223-227
    PubMedGoogle Scholar
  • 223 Counts RB, Haisch C, Simon TL, Maxwell NG, Heimbach DM, Carrico CJ. Hemostasis in massively transfused trauma patients. Ann Surg 1979; 190 (01) 91-99
    CrossrefPubMedGoogle Scholar
  • 224 Harrigan C, Lucas CE, Ledgerwood AM, Mammen EF. Primary hemostasis after massive transfusion for injury. Am Surg 1982; 48 (08) 393-396
    PubMedGoogle Scholar
  • 225 Harrigan C, Lucas CE, Ledgerwood AM, Walz DA, Mammen EF. Serial changes in primary hemostasis after massive transfusion. Surgery 1985; 98 (04) 836-844
    PubMedGoogle Scholar
  • 226 Stevens RF, Alexander MK. A sex difference in the platelet count. Br J Haematol 1977; 37 (02) 295-300
    CrossrefPubMedGoogle Scholar
  • 227 Nieuwenhuis HK, Sixma JJ. Bleeding time measurements. In: Harker LA, Zimmerman TS. eds. Measurements of Platelet Function. New York:: Churchill Livingstone;; 1983: 26-45
    Google Scholar
  • 228 von Willebrand EA, Jurgens R. Uber ein neues vererbbares Blutungsubel: Die konstitutionelle Thrombopathie. Dtsch Arch Klin Med 1933; 175: 453-483
    PubMedGoogle Scholar
  • 229 Biggs R, MacFarlane RG. Haemophilia and related conditions: a survey of 187 cases. Br J Haematol 1958; 4 (01) 1-27
    CrossrefPubMedGoogle Scholar
  • 230 Nilsson IM. Report of the working party on factor VIII-related antigens. Thromb Haemost 1978; 39 (02) 511-520
    Article in Thieme ConnectPubMedGoogle Scholar
  • 231 Brinkhous KM. W. W. Duke and his bleeding time test. A commentary on platelet function. JAMA 1983; 250 (09) 1210-1214
    CrossrefPubMedGoogle Scholar